Amgen Inc (AMGN) operating KPIs
AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026Score 17/3039% above fair value
$466.01+5.28 (+1.15%)
Close on Oct 30, 2026Market cap $251.94BP/E 28.9Yield 2.07%
Latest, FY2023
267
Period ended Dec 31, 2023
Change on a year earlier
–
History
8 years
Since FY2008
Sources
5
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Restructuring charges ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2023 | Dec 31, 2023 | 267 | – | Form 10-K (filed 2024-02-14) ↗ |
| FY2018 | Dec 31, 2018 | 12 | -86.4% | Form 10-K (filed 2019-02-13) ↗ |
| FY2017 | Dec 31, 2017 | 88 | +137.8% | Form 10-K (filed 2019-02-13) ↗ |
| FY2016 | Dec 31, 2016 | 37 | -72.0% | Form 10-K (filed 2019-02-13) ↗ |
| FY2015 | Dec 31, 2015 | 132 | -65.7% | Form 10-K (filed 2016-02-16) ↗ |
| FY2014 | Dec 31, 2014 | 385 | – | Form 10-K (filed 2015-02-19) ↗ |
| FY2009 | Dec 31, 2009 | 34 | -63.0% | Form 10-K (filed 2011-02-25) ↗ |
| FY2008 | Dec 31, 2008 | 92 | – | Form 10-K (filed 2011-02-25) ↗ |
Cite this data
StockData. (2026). Amgen Restructuring charges ($M) ($M), annual FY2008–FY2023 [Data set]. Compiled from Amgen SEC filings and investor materials. https://stockdatahq.com/stocks/amgn/kpis/fs_restruct
See every metric in the Amgen KPI table. Data updated Oct 28, 2026.